Renaissance Technologies Llc ownership in ICUI / ICU Medical, Inc.

ICU Medical, Inc.

US ˙ NasdaqGS ˙ US44930G1076

Security	ICUI / ICU Medical, Inc.
Institution	Renaissance Technologies Llc
Manager	James Simons
Latest Disclosed Ownership	739,700 shares
Ownership	4.53%

2017-02-14 - Renaissance Technologies Llc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 739,700 shares of ICU Medical, Inc. (US:ICUI). This represents 4.53 percent ownership of the company. In their previous filing dated 2016-02-12 , Renaissance Technologies Llc had reported owning 812,800 shares, indicating a decrease of -8.99 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2017-02-14	2017-02-14	13G/A	812,800	739,700	-8.99	4.53	-10.30
2016-02-12	2016-02-12	13G		812,800		5.05

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-14	2026-03-31	13F	ICU MED	COM	44930G107	11,309	-24,991	-68.85	1,461	-71.80	0.0023
2026-02-12	2025-12-31	13F	ICU MED	COM	44930G107	36,300	-33,100	-47.69	5,179	-37.80	0.0080
2025-11-13	2025-09-30	13F	ICU MED	COM	44930G107	69,400	-17,200	-19.86	8,325	-27.25	0.0110
2025-08-13	2025-06-30	13F	ICU MED	COM	44930G107	86,600	77,800	884.09	11,444	837.26	0.0152
2025-05-14	2025-03-31	13F	ICU MED	COM	44930G107	8,800	8,800		1,222		0.0018
2024-11-13	2024-09-30	13F	ICU MED	COM	44930G107	0	-10,000	-100.00	0	-100.00
2024-08-09	2024-06-30	13F	ICU MED	COM	44930G107	10,000	10,000		1,188		0.0020
2023-11-14	2023-09-30	13F	ICU MED	COM	44930G107	0	-86,000	-100.00	0	-100.00
2023-08-11	2023-06-30	13F	ICU MED	COM	44930G107	86,000	58,600	213.87	15	275.00	0.0221
2023-05-12	2023-03-31	13F	ICU MED	COM	44930G107	27,400	18,800	218.60	5	300.00	0.0060
2023-02-13	2022-12-31	13F	ICU MED	COM	44930G107	8,600	-38,600	-81.78	1	-99.99	0.0019
2022-11-14	2022-09-30	13F	ICU MED	COM	44930G107	47,200	-35,300	-42.79	7,108	-47.59	0.0101
2022-08-12	2022-06-30	13F	ICU MED	COM	44930G107	82,500	17,900	27.71	13,562	-5.71	0.0161
2022-05-13	2022-03-31	13F	ICU MED	COM	44930G107	64,600	-10,400	-13.87	14,383	-19.20	0.0169
2022-02-11	2021-12-31	13F	ICU MED	COM	44930G107	75,000	-17,400	-18.83	17,801	-17.45	0.0221
2021-11-12	2021-09-30	13F	ICU MED	COM	44930G107	92,400	37,100	67.09	21,564	89.47	0.0279
2021-08-13	2021-06-30	13F	ICU MED	COM	44930G107	55,300	23,300	72.81	11,381	73.12	0.0142
2021-05-13	2021-03-31	13F	ICU MED	COM	44930G107	32,000	13,200	70.21	6,574	63.05	0.0082
2021-02-10	2020-12-31	13F	ICU MED	COM	44930G107	18,800	-25,000	-57.08	4,032	-49.63	0.0044
2020-11-13	2020-09-30	13F	ICU MED	COM	44930G107	43,800	31,000	242.19	8,005	239.34	0.0080
2020-08-13	2020-06-30	13F	ICU MED	COM	44930G107	12,800	10,400	433.33	2,359	387.40	0.0020
2020-05-14	2020-03-31	13F	ICU MED	COM	44930G107	2,400	2,400	-81.25	484	-79.48	0.0005
2019-11-13	2019-09-30	13F	ICU MED	COM	44930G107	0	-9,100	-100.00	0	-100.00
2019-08-12	2019-06-30	13F	ICU MED	COM	44930G107	9,100	9,100		2,292		0.0020
2019-05-14	2019-03-31	13F	ICU MED	COM	44930G107	0	-76,300	-100.00	0	-100.00
2019-02-12	2018-12-31	13F	ICU MED	COM	44930G107	76,300	-132,789	-63.51	17,521	-70.36	0.0192
2018-11-13	2018-09-30	13F	ICU MED	COM	44930G107	209,089	-103,411	-33.09	59,120	-35.58	0.0608
2018-08-13	2018-06-30	13F/A-1	ICU MED	COM	44930G107	312,500	3,400	1.10	91,766	17.62	0.1000
2018-08-13	2018-06-30	13F	ICU MED	COM	44930G107	309,100			78,017
2018-05-14	2018-03-31	13F	ICU MED	COM	44930G107	309,100	-23,600	-7.09	78,017	8.56	0.0853
2018-02-13	2017-12-31	13F	ICU MED	COM	44930G107	332,700	-110,300	-24.90	71,863	-12.72	0.0792
2017-11-13	2017-09-30	13F	ICU MED	COM	44930G107	443,000	-145,300	-24.70	82,332	-18.87	0.0969
2017-08-11	2017-06-30	13F	ICU MED	COM	44930G107	588,300	-108,549	-15.58	101,482	-4.63	0.1295
2017-05-12	2017-03-31	13F	ICU MED	COM	44930G107	696,849	-42,851	-5.79	106,409	-2.37	0.1487
2017-02-13	2016-12-31	13F	ICU MED	COM	44930G107	739,700	700	0.09	108,995	16.70	0.1724
2016-11-14	2016-09-30	13F	ICU MED	COM	44930G107	739,000	-54,100	-6.82	93,395	4.44	0.1651
2016-08-12	2016-06-30	13F	ICU MED	COM	44930G107	793,100	-48,900	-5.81	89,422	2.02	0.1702
2016-05-13	2016-03-31	13F	ICU MED	COM	44930G107	842,000	29,200	3.59	87,652	-4.38	0.1666
2016-02-11	2015-12-31	13F	ICU MED	COM	44930G107	812,800	50,200	6.58	91,668	9.78	0.1997
2015-11-12	2015-09-30	13F	ICU MED	COM	44930G107	762,600	73,866	10.72	83,505	26.75	0.1993
2015-08-14	2015-06-30	13F	ICU MED	COM	44930G107	688,734	79,034	12.96	65,884	16.02	0.1501
2015-05-13	2015-03-31	13F	ICU MED	COM	44930G107	609,700	64,959	11.92	56,787	27.29	0.1209
2015-02-13	2014-12-31	13F	ICU MED	COM	44930G107	544,741	-13,159	-2.36	44,614	24.60	0.1077
2014-11-12	2014-09-30	13F	ICU MED	COM	44930G107	557,900	-87,600	-13.57	35,806	-8.78	0.0980
2014-08-13	2014-06-30	13F	ICU MED	COM	44930G107	645,500	-86,701	-11.84	39,253	-10.47	0.0915
2014-05-14	2014-03-31	13F	ICU MED	COM	44930G107	732,201	133,701	22.34	43,844	14.99	0.1052
2014-02-14	2013-12-31	13F	ICU MED	COM	44930G107	598,500	203,900	51.67	38,130	42.25	0.0913
2013-11-13	2013-09-30	13F	ICU MED	COM	44930G107	394,600	141,000	55.60	26,805	46.68	0.0650
2013-08-12	2013-06-30	13F	ICU MED	COM	44930G107	253,600	253,600		18,274		0.0479

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.